Abingworth
David Simmons joined PPD in 2012 as chairman and CEO. He leads the company’s global workforce of more than 26,000 employees, across 46 countries, in the design and execution of drug development programs on behalf of pharmaceutical industry customers.
Under his leadership, PPD’s total enterprise value has more than tripled, the number of employees has more than doubled and the company has received numerous accolades.
David came to PPD following 15 years with Pfizer Inc. most recently as president of the emerging markets and established products business units.
This person is not in the org chart
This person is not in any offices
Abingworth
1 followers
Abingworth is an international investment group dedicated to collaborating with life sciences entrepreneurs to develop their ideas into products that have a dramatic impact on health. With over $1 billion under management, Abingworth invests at all stages of development, from start-ups to publicly traded companies, and across all life sciences sectors. Supporting its portfolio companies with a team of 25 at offices in London, Menlo Park, and Boston, Abingworth has invested in 151 life science companies, completed 65 IPOs and 42 mergers and acquisitions.